Corcept Therapeutics: Wilson trust sells 10,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Corcept Therapeutics (CORT) director James N. Wilson reported that the James N. Wilson and Pamela D. Wilson Trust sold 10,000 shares of common stock on November 13, 2026. The four reported weighted-average sale prices were $71.8011, $72.8666, $73.4192 and $74.2800 per share. The sales were made under a 10b5-1 plan adopted March 12, 2026. Wilson has voting power over the trust’s shares and disclaims beneficial ownership except to the extent of his pecuniary interest. Separately reported indirect holdings included 200,000 shares in James N. Wilson 2025 Grantor Retained Annuity Trust and 200,000 shares in Pamela D. Wilson 2025 Grantor Retained Annuity Trust.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F5 | 2,191 | $71.8011 | $157K |
| Sale | Common Stock F1, F3, F5 | 7,221 | $72.8666 | $526K |
| Sale | Common Stock F1, F4, F5 | 563 | $73.4192 | $41K |
| Sale | Common Stock F1, F5 | 25 | $74.28 | $2K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction.
- F2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $71.18 to $72.17 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F3. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $72.18 to $73.155 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F4. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.22 to $73.88 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F5. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
Key Figures
Key Terms
10b5-1 plan financial
weighted average sale price financial
pecuniary interest financial
Grantor Retained Annuity Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.